Defining a CXCR3-associated gene signature as a predictive biomarker and alternate target of immunotherapy across molecular subtypes of breast cancer
Research Grant
Administered By
Surgery, Surgical Sciences
Awarded By
National Cancer Institute
Start Date
September 1, 2022
End Date
August 31, 2025
Administered By
Surgery, Surgical Sciences
Awarded By
National Cancer Institute
Start Date
September 1, 2022
End Date
August 31, 2025